Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen
- PMID: 20367282
- PMCID: PMC3135251
- DOI: 10.1089/scd.2009.0326
Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen
Abstract
Human embryonic stem cells (hESC) require a balance of growth factors and signaling molecules to proliferate and retain pluripotency. Conditioned medium (CM) from a human embryonic germ-cell-derived cell culture, SDEC, was observed to support the growth of hESC on type I collagen (COL I) and on Matrigel (MAT) biomatricies. After 1 month, the population doubling of hESC grown in SDEC CM on COL I was equivalent to that of hESC grown in mouse embryonic fibroblast (MEF) CM on MAT. hESC grown in SDEC CM on COL I expressed OCT4, NANOG, SSEA-4, alkaline phosphatase (AP), and TRA-1-60; retained a normal karyotype; and were capable of forming teratomas. DNA microarray analysis was used to compare the transcriptional profiles of SDEC and the less supportive WI38 and Detroit 551 human cell lines. The mRNA level of secreted frizzled-related protein (sFRP-1), a known antagonist of the WNT/β-catenin signaling pathway, was significantly reduced in SDEC as compared with the other 2 cell lines, whereas the mRNA levels of prostaglandin-endoperoxide synthase 2 (PTGS2 or COX-2) and prostaglandin I₂ synthase (PGIS), two prostaglandin biosynthesis genes, were significantly increased in SDEC. The level of sFRP-1 protein was significantly reduced, and levels of 2 prostaglandins that are downstream products of PTGS2 and PGIS, prostaglandin E₂ and 6-keto-prostaglandin F(1α), were significantly elevated in SDEC CM compared with WI38, Detroit 551, and MEF CM. Further, addition of purified sFRP-1 to SDEC CM reduced the proliferation of hESC grown on COL I as well as MAT in a dose-dependent manner.
Figures





Similar articles
-
Noggin maintains pluripotency of human embryonic stem cells grown on Matrigel.Cell Prolif. 2009 Aug;42(4):425-33. doi: 10.1111/j.1365-2184.2009.00616.x. Epub 2009 Jun 2. Cell Prolif. 2009. PMID: 19500111 Free PMC article.
-
Analysis of the factors that limit the ability of feeder cells to maintain the undifferentiated state of human embryonic stem cells.Stem Cells Dev. 2009 May;18(4):641-51. doi: 10.1089/scd.2008.0010. Stem Cells Dev. 2009. PMID: 18764735 Free PMC article.
-
Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.Methods Cell Biol. 2008;86:15-28. doi: 10.1016/S0091-679X(08)00002-2. Methods Cell Biol. 2008. PMID: 18442642
-
Nanog and transcriptional networks in embryonic stem cell pluripotency.Cell Res. 2007 Jan;17(1):42-9. doi: 10.1038/sj.cr.7310125. Cell Res. 2007. PMID: 17211451 Review.
-
Differences between human embryonic stem cell lines.Hum Reprod Update. 2007 Mar-Apr;13(2):103-20. doi: 10.1093/humupd/dml041. Epub 2006 Aug 26. Hum Reprod Update. 2007. PMID: 16936306 Review.
Cited by
-
Defining synthetic surfaces for human pluripotent stem cell culture.Cell Regen. 2013 Nov 22;2(1):7. doi: 10.1186/2045-9769-2-7. eCollection 2013. Cell Regen. 2013. PMID: 25408879 Free PMC article. Review.
-
ECM-incorporated hydrogels cross-linked via native chemical ligation to engineer stem cell microenvironments.Biomacromolecules. 2013 Sep 9;14(9):3102-11. doi: 10.1021/bm400728e. Epub 2013 Aug 20. Biomacromolecules. 2013. PMID: 23875943 Free PMC article.
-
Cell fiber-based three-dimensional culture system for highly efficient expansion of human induced pluripotent stem cells.Sci Rep. 2017 Jun 6;7(1):2850. doi: 10.1038/s41598-017-03246-2. Sci Rep. 2017. PMID: 28588295 Free PMC article.
-
Effects of high-mobility group a protein application on canine adipose-derived mesenchymal stem cells in vitro.Vet Med Int. 2012;2012:752083. doi: 10.1155/2012/752083. Epub 2012 Feb 8. Vet Med Int. 2012. PMID: 22448338 Free PMC article.
-
Biomaterial strategies for stem cell maintenance during in vitro expansion.Tissue Eng Part B Rev. 2014 Aug;20(4):340-54. doi: 10.1089/ten.TEB.2013.0349. Epub 2013 Dec 5. Tissue Eng Part B Rev. 2014. PMID: 24168361 Free PMC article. Review.
References
-
- Odorico JS. Kaufman DS. Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19:193–204. - PubMed
-
- Ho HY. Li M. Potential application of embryonic stem cells in Parkinson's disease: drug screening and cell therapy. Regen Med. 2006;1:175–182. - PubMed
-
- Porat S. Dor Y. New sources of pancreatic beta cells. Curr Diab Rep. 2007;7:304–308. - PubMed
-
- Shamblott MJ. Clark GO. Cell therapies for type 1 diabetes mellitus. Expert Opin Biol Ther. 2004;4:269–277. - PubMed
-
- Scharfmann R. Alternative sources of beta cells for cell therapy of diabetes. Eur J Clin Invest. 2003;33:595–600. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials